Grants > Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma Updated On: Jul 2, 2026
National Glaucoma Research Grant

Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma

Protecting & Regenerating the Optic Nerve
a headshot of Evan Cameron, PhD

Principal Investigator

Evan Cameron, PhD

Cleveland Clinic - Lerner Research Institute

Cleveland, OH, United States

About the Research Project

Program

National Glaucoma Research

Award Type

Standard

Award Amount

$150,000

Active Dates

July 01, 2026 - June 30, 2028

Grant ID

G2026003S

Goals

The goal of this project is to investigate the effects of aging and elevated intraocular pressure on optic nerve head (ONH) astrocyte gene expression and function.

Summary

This project aims to define the signaling pathways in optic nerve head (ONH) astrocytes that regulate immune cell-mediated neurodegeneration in glaucoma to guide the development of novel therapeutic strategies.

Unique and Innovative

This project will utilize an inducible mouse model of glaucoma in combination with novel gene therapy vectors to directly study the astrocyte population hypothesized to drive disease progression. Conceptual advances include defining the unique and shared contributions of age and elevated intraocular pressure to glaucoma, and identification of novel regulators of ONH astrocyte gene expression underlying degenerative functions.

Foreseeable Benefits

This work will serve as the foundation for future astrocyte-targeted therapeutics designed to mitigate or reverse the effects of glaucoma, significantly improving patient vision and quality of life.